Citation Impact
Citing Papers
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Hallmarks of Cancer: The Next Generation
2011 Standout
Reading the glyco-code: New approaches to studying protein–carbohydrate interactions
2022 StandoutNobel
Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis
1998
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
2007 Standout
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
2014 Standout
CD44: From adhesion molecules to signalling regulators
2003 Standout
Everolimus for Advanced Pancreatic Neuroendocrine Tumors
2011 Standout
Multistage Nanoparticles for Improved Delivery into Tumor Tissue
2012 StandoutNobel
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
TGF-β signaling in tumor suppression and cancer progression
2001 Standout
Parkinson's disease: clinical features and diagnosis
2008 Standout
Super pH-sensitive multifunctional polymeric micelle for tumor pHe specific TAT exposure and multidrug resistance
2008
Stimuli-responsive nanocarriers for drug delivery
2013 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Activation of microvascular pericytes in autoimmune Raynaud's phenomenon and systemic sclerosis
1999
Scleroderma
2009 Standout
PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing
2008 Standout
Hydrogel nanoparticles in drug delivery
2008 Standout
The CD44 Proteins in Embryonic Development and in Cancer
1996
Multiple sclerosis
2008 Standout
Cancer genes and the pathways they control
2004 Standout
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
2006 Standout
Expression of Growth Factors and Their Receptors in Neuroendocrine Gut and Pancreatic Tumors, and Prognostic Factors for Survival
1994
Neuroendocrine gastrointestinal tumours
1996
Signals controlling the expression of PDGF
1996
Pericytes: Developmental, Physiological, and Pathological Perspectives, Problems, and Promises
2011 Standout
Constitutive Protease-activated Receptor-2-mediated Migration of MDA MB-231 Breast Cancer Cells Requires Both β-Arrestin-1 and -2
2004 StandoutNobel
Involvement of platelet-derived growth factor in disease: development of specific antagonists
2001
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Amplification of thePlatelet-Derived Growth Factor Receptor-A(PDGFRA) Gene Occurs in Oligodendrogliomas with Grade IV Anaplastic Features
2000
Carcinoid A Comprehensive Review
2003
Combined comparative genomic hybridization and genomic microarray for detection of gene amplifications in pulmonary artery intimal sarcomas and adrenocortical tumors
2002
Striatal deformities of the hand and foot in Parkinson's disease
2005
Going viral with cancer immunotherapy
2014
Federated learning in medicine: facilitating multi-institutional collaborations without sharing patient data
2020 Standout
Molecular Targeted Therapy for Neuroendocrine Tumors
2007
A 5‐decade analysis of 13,715 carcinoid tumors
2003 Standout
The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase
1995 Standout
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
TGF-β and fibrosis
1999
Overview of the clinical efficacy of investigational anticancer drugs
2003
VEGF-targeted therapy: mechanisms of anti-tumour activity
2008 Standout
Molecular targeted therapy for carcinoid and islet-cell carcinoma
2007
Recent progress in tumor pH targeting nanotechnology
2008
An analysis of 8305 cases of carcinoid tumors
2000 Standout
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Unique microRNA molecular profiles in lung cancer diagnosis and prognosis
2006 Standout
Small-cell lung cancer
2005
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Platelet-derived growth factor plays a critical role to convert bone marrow cells into glomerular mesangial-like cells
2003 StandoutNobel
PDGF and its receptors following facial nerve axotomy in rats: expression in neurons and surrounding glia
1995
Down-regulation of invasion and angiogenesis-related genes identified by cDNA microarray analysis of PC3 prostate cancer cells treated with genistein
2002
Magnesium supplementation prevents experimental chronic cyclosporine a nephrotoxicity via renin-angiotensin system independent mechanism.
2002 StandoutNobel
Multiple sclerosis
2002 Standout
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)-Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer
2019
Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms.
1993
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
2008
The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
2015
Autonomous in Vitro Anticancer Drug Release from Mesoporous Silica Nanoparticles by pH-Sensitive Nanovalves
2010 StandoutNobel
Messenger ribonucleic acid expression of platelet-derived growth factor subunits and receptors in pituitary adenomas.
1994
Biochemical diagnosis of neuroendocrine GEP tumor.
1999
Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells.
2000
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
2001 Standout
Metabolic Dysregulation and Adipose Tissue Fibrosis: Role of Collagen VI
2008 Standout
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
Going Digital: A Survey on Digitalization and Large-Scale Data Analytics in Healthcare
2016
The latent transforming growth factor β binding protein (LTBP) family
2000
The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic
2015
Molecular Genetics of Lung Cancer
2003
The Effect of Nanoparticle Size, Shape, and Surface Chemistry on Biological Systems
2012 Standout
One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States
2008 Standout
Angiogenesis in Endocrine Tumors
2003
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Expression of molecular targets for tyrosine kinase receptor antagonists in malignant endocrine pancreatic tumors.
2003
Regulation of Wound Healing by Growth Factors and Cytokines
2003 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of Arvind Chaudhry being referenced
Expression of Growth Factor Peptides and Their Receptors in Neuroendocrine Tumors of the Digestive System
1993
Extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation Ad5 [E1-, E2b-]-CEA(6D) vaccine in late-stage colorectal cancer
2015
Novel adenoviral vector induces T-cell responses despite anti-adenoviral neutralizing antibodies in colorectal cancer patients
2013
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
1999
Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system.
1995
Different splice variants of CD44 are expressed in gastrinomas but not in other subtypes of endocrine pancreatic tumors.
1994
Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system.
1992